Drug Shortage Report for APO-TADALAFIL
Report ID | 144669 |
Drug Identification Number | 02422107 |
Brand name | APO-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 BLS |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-08-24 |
Estimated end date | 2021-09-10 |
Actual end date | 2021-09-10 |
Shortage status | Resolved |
Updated date | 2021-09-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-09-14 | French | Compare |
v3 | 2021-09-14 | English | Compare |
v2 | 2021-08-27 | French | Compare |
v1 | 2021-08-27 | English | Compare |
Showing 1 to 4 of 4